|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -99.33% |
| 06/08 | Morphic Medical Announces Board Appointments, Effective August 6, 2026 | CI |
| 03/08 | Morphic Medical Inc. Provides Update On Reset System Clinical And Commercial Progress | CI |
| Market Cap | 440K 387K 366K 332K 624K 42.28M 628K 4.39M 1.69M 21.58M 1.65M 1.62M 69.33M | P/E 2019 |
-1.12x | P/E 2020 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 3.28M 2.88M 2.73M 2.47M 4.65M 315M 4.67M 32.66M 12.61M 161M 12.31M 12.05M 516M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
-
| Yield 2019 * |
-
| Yield 2020 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mike Gutteridge
CEO | Chief Executive Officer | - | 05/08/2025 |
Jane Wright
DFI | Director of Finance/CFO | 57 | 01/08/2025 |
| Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Ginger Glaser
BRD | Director/Board Member | - | 20/10/2020 |
Alex Escalona
BRD | Director/Board Member | - | - |
John R. Barr
BRD | Director/Board Member | 69 | 01/10/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/1/21 | Free | Chairman | 1,384,483 | 0.4875% | ||
| 28/1/21 | Free | Chief Executive Officer | 11,075,869 | 3.8998% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -17.33M -15.24M -14.42M -13.07M -24.56M -1.66B -24.7M -173M -66.66M -849M -65.08M -63.67M -2.73B | -11.14M -9.79M -9.26M -8.4M -15.78M -1.07B -15.87M -111M -42.83M -545M -41.81M -40.9M -1.75B |
| Net Debt | 2.89M 2.54M 2.4M 2.18M 4.09M 277M 4.11M 28.75M 11.1M 141M 10.84M 10.6M 454M | 2.84M 2.5M 2.36M 2.14M 4.02M 273M 4.05M 28.27M 10.92M 139M 10.66M 10.43M 447M |
Employees
-
Sector
-
- Stock Market
- Stocks
- GIDYL Stock
Select your edition
All financial news and data tailored to specific country editions
















